Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...